Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Invested CapitalReturn on SalesTimes Interest Earned

Burning Rock Biotech (BNR) Return on Invested Capital (2022 - 2025)

Historic Return on Invested Capital for Burning Rock Biotech (BNR) over the last 2 years, with Q3 2025 value amounting to 582.09%.

  • Burning Rock Biotech's Return on Invested Capital changed N/A to 582.09% in Q3 2025 from the same period last year, while for Sep 2025 it was 582.09%, marking a year-over-year change of. This contributed to the annual value of 0.51% for FY2024, which is 1700.0% up from last year.
  • Per Burning Rock Biotech's latest filing, its Return on Invested Capital stood at 582.09% for Q3 2025.
  • Burning Rock Biotech's Return on Invested Capital's 5-year high stood at 1.32% during Q2 2022, with a 5-year trough of 582.09% in Q3 2025.